Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANAMORELIN vs ANGIOTENSIN II: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANAMORELIN vs ANGIOTENSIN II: Safety Overview

Metric ANAMORELIN ANGIOTENSIN II
Total FAERS Reports 130 181
Deaths Reported 43 60
Death Rate 33.1% 33.1%
Hospitalizations 72 68
Average Patient Age 71.5 yrs 47.8 yrs
% Female Patients 32.3% 30.4%
FDA Approval Date N/A Dec 21, 2017
Manufacturer N/A La Jolla Pharmaceutical Company
Route N/A INTRAVENOUS
Marketing Status N/A Prescription